The FDA recently approved semaglutide (Wegovy) for preventing serious heart conditions in some people, but questions remain ...
Looking to lose weight by summer? Don't fall for a fad diet. These are seven easy things a dietitian would do to shed pounds ...
Technically, you can lose weight just by eating less food, without adding exercise at all. But is that a good idea? Not at all. Exercise is good for us, in terms of heart health, mental health ...
A registered dietitian shares five of the best weight-loss diets for seniors that focus on nutrient-dense foods and balanced ...
The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in ...
Novo Nordisk’s weight loss medication Wegovy received approval on Friday for reducing the risk of cardiovascular death, heart attack and stroke in patients with cardiovascular disease and obesity.
It's the first weight-loss drug to carry an indication for heart benefits. The U.S. Food and Drug Administration (FDA) approved the addition to the label on March 8 based on a study from Wegovy ...
(Tom Little/Reuters) The U.S. Food and Drug Administration approved the weight-loss drug Wegovy as a treatment to reduce cardiovascular risk in adults who are overweight, the first approval of its ...
March 21 (UPI) --Medicare now will cover Wegovy after the Food and Drug Administration cleared the manufacturer to market the popular weight-loss drug as a treatment for heart problems.
Wegovy has been approved for use as a heart disease prevention medication, the FDA announced on Friday. The injectable semaglutide — originally approved for weight loss for certain patients ...
The obesity drug Wegovy can now claim to lower the risk of heart attack, stroke, and other cardiovascular issues in people ...